Tag

Sales Forecast

All articles tagged with #sales forecast

Nintendo hikes Switch 2 price worldwide as sales outlook dims
gaming19 days ago

Nintendo hikes Switch 2 price worldwide as sales outlook dims

Nintendo is raising Switch 2 prices globally (US $499.99 from $449.99; Canada $679.99; Europe €499.99; Japan’s price bump comes earlier) and broader Switch-family pricing changes in Japan, while forecasting a sales dip. In FY26 the Switch 2 sold 19.86 million units; FY27 is expected to reach 16.5 million, with an anticipated revenue hit from higher memory prices and tariffs. The moves follow similar price hikes from Sony and Microsoft.

Nintendo hikes Switch 2 price as memory-chip crunch bites sales outlook
business19 days ago

Nintendo hikes Switch 2 price as memory-chip crunch bites sales outlook

Nintendo will raise the Switch 2 price in the U.S. by $50 to $499.99 (with price hikes in Japan, Canada and Europe) due to surging memory-chip costs, and it now expects to sell 16.5 million Switch 2 units for the fiscal year ending March 31, 2027 (down from 19.86 million), with an estimated ~100 billion yen hit to earnings and a profit shortfall versus analyst forecasts.

Apple's iPhone 17 Drives Record Sales and Optimistic Outlook
technology6 months ago

Apple's iPhone 17 Drives Record Sales and Optimistic Outlook

Apple's CEO Tim Cook forecasts holiday quarter iPhone sales and revenue that surpass Wall Street estimates, driven by strong demand for iPhone 17 models despite supply constraints and delays in China. The company expects double-digit iPhone sales growth and a 10-12% increase in overall revenue for Q1 2026, with particular strength in base and Pro models, while addressing ongoing supply issues and trade tensions.

Hims & Hers Stock Declines Amid Revenue Miss and Growth Concerns
business9 months ago

Hims & Hers Stock Declines Amid Revenue Miss and Growth Concerns

Hims & Hers stock dropped over 11% after missing Wall Street's Q2 sales forecast despite higher profits, as the company shifts focus to personalized healthcare and faces challenges in its obesity-related business. The company maintains its annual sales guidance but faces scrutiny over its core business and recent market performance, amid a broader industry context involving weight-loss drugs and strategic partnerships.